Intra-Cellular
Therapies is a New York-based biopharmaceutical company that researches and develops small-molecule drugs for the treatment of central nervous system disorders... Read moreIntra-Cellular
Therapies is a New York-based biopharmaceutical company that researches and develops small-molecule drugs for the treatment of central nervous system disorders... Read more
News
Acquisition
Jan 13, 2025
mlex.com
Intra-Cellular Was acquired by Johnson & Johnson Services, Inc. for $14.6B
Conference Presentation
Nov 19, 2024
GlobeNewswire
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
Funding
Apr 24, 2024
GlobalNewswire
Intra-Cellular received $575M in Post-IPO Equity Funding
Intra-Cellular Competitors
1
2
3
4
5
6
7